(Q43226325)

English

Multiscale kinetic modeling of liposomal Doxorubicin delivery quantifies the role of tumor and drug-specific parameters in local delivery to tumors

scientific article published on 21 November 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 November 2017

Multiscale kinetic modeling of liposomal Doxorubicin delivery quantifies the role of tumor and drug-specific parameters in local delivery to tumors (English)

1 reference

Europe PubMed Central

PMC publication ID

16 November 2017

1 reference

based on heuristic

inferred from title

author name string

B S Hendriks

1

1 reference

Europe PubMed Central

PMC publication ID

16 November 2017

J G Reynolds

2

1 reference

Europe PubMed Central

PMC publication ID

16 November 2017

S G Klinz

3

1 reference

Europe PubMed Central

PMC publication ID

16 November 2017

E Geretti

4

1 reference

Europe PubMed Central

PMC publication ID

16 November 2017

H Lee

5

1 reference

Europe PubMed Central

PMC publication ID

16 November 2017

S C Leonard

6

1 reference

Europe PubMed Central

PMC publication ID

16 November 2017

D F Gaddy

7

1 reference

Europe PubMed Central

PMC publication ID

16 November 2017

C W Espelin

8

1 reference

Europe PubMed Central

PMC publication ID

16 November 2017

U B Nielsen

9

1 reference

Europe PubMed Central

PMC publication ID

16 November 2017

T J Wickham

10

1 reference

Europe PubMed Central

PMC publication ID

16 November 2017

publication date

21 November 2012

1 reference

Europe PubMed Central

PMC publication ID

16 November 2017

CPT: pharmacometrics & systems pharmacology

1 reference

Europe PubMed Central

PMC publication ID

16 November 2017

1

1 reference

Europe PubMed Central

PMC publication ID

16 November 2017

e15

1 reference

Europe PubMed Central

PMC publication ID

16 November 2017

HER2-targeted liposomal doxorubicin displays enhanced anti-tumorigenic effects without associated cardiotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

25 May 2018

Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

25 May 2018

Delivering nanomedicine to solid tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

25 May 2018

Imaging nanoprobe for prediction of outcome of nanoparticle chemotherapy by using mammography.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

25 May 2018

A compartment model of VEGF distribution in blood, healthy and diseased tissues.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

25 May 2018

Quantitative correlation between (1)H MRS and dynamic contrast-enhanced MRI of human breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

25 May 2018

Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

25 May 2018

Targeting neuropilin-1 to inhibit VEGF signaling in cancer: Comparison of therapeutic approaches

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

25 May 2018

Drug penetration in solid tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

25 May 2018

Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

25 May 2018

Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

25 May 2018

Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

25 May 2018

High intratumoural accumulation of stealth liposomal doxorubicin (Caelyx) in glioblastomas and in metastatic brain tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

25 May 2018

A mathematical model for comparison of bolus injection, continuous infusion, and liposomal delivery of doxorubicin to tumor cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

25 May 2018

Mechanism of action of P-glycoprotein in relation to passive membrane permeation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

25 May 2018

Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

25 May 2018

Cytotoxicity and DNA binding characteristics of dextran-conjugated doxorubicins.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

25 May 2018

Quantitative analysis of liposome-cell interactions in vitro: rate constants of binding and endocytosis with suspension and adherent J774 cells and human monocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

25 May 2018

Biodistribution of monoclonal antibodies: scale-up from mouse to human using a physiologically based pharmacokinetic model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

25 May 2018

A clinicopathologic analysis of adriamycin cardiotoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

25 May 2018

Transport of molecules in the tumor interstitium: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

25 May 2018

Anthracycline incorporation in human lymphocytes. Kinetics of uptake and nuclear concentration.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

25 May 2018

Kinetics of daunorubicin transport by P-glycoprotein of intact cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

25 May 2018

Transport and storage of daunorubicin and doxorubicin in cultured fibroblasts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

25 May 2018

DNA-binding parameters of daunorubicin and doxorubicin in the conditions used for studying the interaction of anthracycline-DNA complexes with cells in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

25 May 2018

Risk factors for doxorubicin-induced congestive heart failure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

25 May 2018

Quantitative study of doxorubicin in living cell nuclei by microspectrofluorometry.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

25 May 2018

64Cu loaded liposomes as positron emission tomography imaging agents.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

15 August 2018

Uptake and intracellular processing of PEG-liposomes and PEG-immunoliposomes by kupffer cells in vitro 1 *.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

15 August 2018

Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

15 August 2018

Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

15 August 2018

Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

15 August 2018

Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3600732

15 August 2018

Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer and head and neck cancer

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2012.16

31 March 2020

Interaction of daunomycin and its derivatives with DNA

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2012.16

31 March 2020

Optimization of antitumor effect of liposomally encapsulated doxorubicin based on simulations by pharmacokinetic/pharmacodynamic modeling

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2012.16

31 March 2020

Indium-111-labelled liposomes: dosimetry and tumour detection in patients with cancer

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2012.16

31 March 2020

Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2012.16

31 March 2020

Comparison of the binding of anthracycline derivatives to purified DNA and to cell nuclei

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2012.16

31 March 2020

Fluorescence stopped-flow kinetic analysis of anthracyclines-DNA interaction

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2012.16

31 March 2020

The interaction of daunorubicin and doxorubicin with DNA and chromatin

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2012.16

31 March 2020

Kinetic studies of anthracycline-DNA interaction by fluorescence stopped flow confirm a complex association mechanism

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2012.16

31 March 2020

Dissociation kinetics of DNA-anthracycline and DNA-anthraquinone complexes determined by stopped-flow spectrophotometry

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2012.16

31 March 2020

Rate of biodistribution of STEALTH liposomes to tumor and skin: influence of liposome diameter and implications for toxicity and therapeutic activity

1 reference

https://api.crossref.org/works/10.1038%2FPSP.2012.16

31 March 2020

Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23835797

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/PSP.2012.16

1 reference

Europe PubMed Central

PMC publication ID

16 November 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43226325&oldid=1984184120"